title: Anti-TNF-α therapy prevents the recurrence of joint bleeding in haemophilia and arthritis.
authors.affiliation: Rheumatology, Villa Monna Tessa, Viale Pieraccini 18,50134 Florence, Italy. daniela.melchiorre@unifi.it.
authors.forename: Daniela
authors.initials: D
authors.lastname: Melchiorre
authors.forename: Massimo
authors.initials: M
authors.lastname: Morfini
authors.forename: Silvia
authors.initials: S
authors.lastname: Linari
authors.forename: Anna Linda
authors.initials: AL
authors.lastname: Zignego
authors.forename: Massimo
authors.initials: M
authors.lastname: Innocenti
authors.forename: Marco
authors.initials: M
authors.lastname: Matucci Cerinic
mesh_terms: D000068879:Adalimumab; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001168:Arthritis / Q000150:complications* / Q000453:epidemiology; D015897:Comorbidity; D006395:Hemarthrosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D006467:Hemophilia A / Q000150:complications* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D055502:Secondary Prevention; D013585:Synovitis / Q000453:epidemiology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab